TLTFF Theralase Technologies Inc.

Theralase Technologies, Inc. engages in the design, development, and manufacture of patented laser technology platforms used in bio-stimulative and bio-destructive clinical applications in patients. It operates through the Medical Laser Technology (MLT), and Anti-Cancer Technology (ACT) segments. The MLT segment focuses on the company's medical laser business, which researches, develops, commercializes and manufactures lasers used by the ACT division. The ACT segment research and development of photo dynamic compounds (PDCs) for the treatment of cancer. The company was founded by Roger J. Dumoulin-White on August 22, 1989 and is headquartered in Toronto, Canada.

This security is traded over-the-counter, or OTC. We don't always have accurate pricing data on OTC stocks.

$0.27    OTCQB
As of 01/24/2022     OTCMarkets


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  Canada
Country of incorporation:  
IPO date:  10/15/2002
Outstanding shares:  204,275,875
Average volume:  136,216
Market cap:   $54,316,955
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      
Valuation   (See tab for details)
PE ratio:   -13.75
PB ratio:   8.71
PS ratio:   56.09
Return on equity:   -63.64%
Net income %:   -414.32%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy